Sodium 4-aminosalicylate dihydrate structure
|
Common Name | Sodium 4-aminosalicylate dihydrate | ||
---|---|---|---|---|
CAS Number | 6018-19-5 | Molecular Weight | 211.148 | |
Density | N/A | Boiling Point | 380.8ºC at 760 mmHg | |
Molecular Formula | C7H10NNaO5 | Melting Point | 250 °C | |
MSDS | Chinese USA | Flash Point | 184.1ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of Sodium 4-aminosalicylate dihydrateSodium 4-aminosalicylate dihydrate is one of the antimycobacterial drugs currently used for multidrug-resistant tuberculosis. |
Name | Sodium 4-aminosalicylate dihydrate |
---|---|
Synonym | More Synonyms |
Description | Sodium 4-aminosalicylate dihydrate is one of the antimycobacterial drugs currently used for multidrug-resistant tuberculosis. |
---|---|
Related Catalog | |
References |
Boiling Point | 380.8ºC at 760 mmHg |
---|---|
Melting Point | 250 °C |
Molecular Formula | C7H10NNaO5 |
Molecular Weight | 211.148 |
Flash Point | 184.1ºC |
Exact Mass | 211.045670 |
PSA | 104.84000 |
Water Solubility | soluble |
Synonym:PAS; 4-Amino-2-Hydroxybenzoic Acid Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 36/37/38 Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Light sensitive.Air sensitive. Potential Health Effects Eye: Causes eye irritation. May cause chemical conjunctivitis. Skin: Causes skin irritation. Ingestion: May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause liver damage. Inhalation: Causes respiratory tract irritation. Can produce delayed pulmonary edema. Chronic: Effects may be delayed. Chronic exposure may cause liver damage. Section 4 - FIRST AID MEASURES Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Ingestion: Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Extinguishing Media: Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Place under an inert atmosphere. Section 7 - HANDLING and STORAGE Handling: Wash thoroughly after handling. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Store protected from light. Handle under an inert atmosphere. Store protected from air. Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Do not expose to air. Store protected from light. Store under an inert atmosphere. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 6018-19-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Crystals Color: white Odor: Odorless or slight acetous pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 250 deg C Autoignition Temperature: Not applicable. Flash Point: Not applicable. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: > 250 deg C Solubility in water: soluble Specific Gravity/Density: >1.0 Molecular Formula: C7H6NO3Na.2H2O Molecular Weight: 211.15 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable at room temperature in closed containers under normal storage and handling conditions. Conditions to Avoid: Incompatible materials, light, dust generation, exposure to air, excess heat. Incompatibilities with Other Materials: Air, strong oxidizing agents. Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide. Hazardous Polymerization: Has not been reported. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 6018-19-5 unlisted. LD50/LC50: Not available. Carcinogenicity: 4-Aminosalicylic Acid Sodium Salt Dihydrate - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XI Risk Phrases: R 36/37/38 Irritating to eyes, respiratory system and skin. Safety Phrases: S 24/25 Avoid contact with skin and eyes. WGK (Water Danger/Protection) CAS# 6018-19-5: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 6018-19-5 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 6018-19-5 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi: Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2918219000 |
HS Code | 2922509090 |
---|---|
Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Adsorption of phenolic compounds from aqueous solution using salicylic acid type adsorbent.
J. Hazard. Mater. 201-202 , 74-81, (2012) In this study, 5-aminosalicylic acid (5-ASA) was successfully grafted onto the poly(glycidyl methacrylate) (PGMA) macromolecular chains of PGMA/SiO(2) to obtain adsorbent ASA-PGMA/SiO(2). The adsorpti... |
|
Comparison between 5-aminosalicylic acid (5-ASA) and para-aminosalicylic acid (4-PAS) as potential protectors against Mn-induced neurotoxicity.
Biol. Trace Elem. Res. 152(1) , 113-6, (2013) Manganese (Mn) is an essential metal for biological systems; however, occupational or clinical exposure to high levels of Mn can produce a neurological disorder called manganism. Oxidative stress and ... |
|
Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice.
Drug Metab. Dispos. 39(5) , 882-90, (2011) Human arylamine N-acetyltransferase 2 (NAT2) mediates the biotransformation of arylamine drugs and procarcinogens into either innocuous or reactive DNA-damaging metabolites and is expressed predominan... |
Sodium 4-Aminosalicylate |
EINECS 205-091-2 |
4-amino-2-hydroxybenzoic acid sodium salt dihydrate |
Benzoic acid, 4-amino-2-hydroxy-, monosodium salt, dihydrate |
Benzoic acid, 4-amino-2-hydroxy-, sodium salt, hydrate (1:1:2) |
4-Aminosalicylic acid sodium salt dihydrate |
AMINOSALICYLATE SODIUM,DIHYDRATE |
4-AMINOSALICYLIC ACID,NA SALT |
Sodium 4-amino-2-hydroxybenzoate dihydrate |
4-AMINOSALICYLIC ACID SODIUM SALT 2-HYDRATE |
4-Amino-2-hydroxy-benzoesaeure,Natrium-Salz |
4-AMINOSALICYLIC ACID SODIUM DIHYDRATE |
sodium p-aminosalicylate dihydrate |
SODIUM AMINOSALICYLA |
4-amino-2-hydroxy-benzoic acid,sodium-salt |
4-amino-salicylic acid sodium salt |
AMINOSALICYLATESODIUM,DIHYDRATE,USP |
UNII-S38B9W6AXW |
PAS-NA 2H2O |
Sodium 4-aminosalicy |
MFCD00151044 |
Sodium 4-amino-2-hydroxybenzoate hydrate (1:1:2) |